Back to Search Start Over

BRAF V600E mutation-assisted risk stratification of solitary intrathyroidal papillary thyroid cancer for precision treatment

BRAF V600E mutation-assisted risk stratification of solitary intrathyroidal papillary thyroid cancer for precision treatment

Authors :
National Institutes of Health (US)
National Science Centre (Poland)
Queensland Government
Ministerio de Economía y Competitividad (España)
European Commission
Fundación Científica Asociación Española Contra el Cáncer
Instituto de Salud Carlos III
Associazione Italiana per la Ricerca sul Cancro
Fondazione Cassa di Risparmio di Perugia
Beadle Family Foundation
Ministry of Health of the Czech Republic
University of New South Wales (Australia)
Ministero della Salute
Ministero dell'Istruzione, dell'Università e della Ricerca
National Natural Science Foundation of China
Huang, Yueye
Qu, Shen
Zhu, Guangwu
Wang, Fei
Liu, Rengyun
Shen, Xiaopei
Viola, David
Elisei, Rossella
Puxeddu, Efisio
Fugazzola, Laura
Colombo, Carla
Jarzab, Barbara
Czarniecka, Agnieszka
Lam, Alfred K.
Mian, Caterina
Vianello, Federica
Yip, Linwah
Riesco-Eizaguirre, Garcilaso
Santisteban, Pilar
O’Neill, Christine J.
Sywak, Mark S.
Clifton-Bligh, Roderick
Bendlova, Bela
Sýkorová, Vlasta
Xing, Mingzhao
National Institutes of Health (US)
National Science Centre (Poland)
Queensland Government
Ministerio de Economía y Competitividad (España)
European Commission
Fundación Científica Asociación Española Contra el Cáncer
Instituto de Salud Carlos III
Associazione Italiana per la Ricerca sul Cancro
Fondazione Cassa di Risparmio di Perugia
Beadle Family Foundation
Ministry of Health of the Czech Republic
University of New South Wales (Australia)
Ministero della Salute
Ministero dell'Istruzione, dell'Università e della Ricerca
National Natural Science Foundation of China
Huang, Yueye
Qu, Shen
Zhu, Guangwu
Wang, Fei
Liu, Rengyun
Shen, Xiaopei
Viola, David
Elisei, Rossella
Puxeddu, Efisio
Fugazzola, Laura
Colombo, Carla
Jarzab, Barbara
Czarniecka, Agnieszka
Lam, Alfred K.
Mian, Caterina
Vianello, Federica
Yip, Linwah
Riesco-Eizaguirre, Garcilaso
Santisteban, Pilar
O’Neill, Christine J.
Sywak, Mark S.
Clifton-Bligh, Roderick
Bendlova, Bela
Sýkorová, Vlasta
Xing, Mingzhao
Publication Year :
2018

Abstract

[Background]: Precise risk stratification-based treatment of solitary intrathyroidal papillary thyroid cancer (SI-PTC) that is larger than 1.0 cm and 4.0 cm or less is undefined. [Methods]: A genetic-clinical risk study was performed on BRAF V600E in 955 patients (768 women and 187 men) with SI-PTC, with median age of 46 years and median clinical follow–up time of 64 months at 11 medical centers in six countries. The chi-square test or, for analyses with small numbers, Fisher’s exact test was performed to compare recurrence rates. Recurrence-free probability was estimated by Kaplan-Meier (KM) analysis, and the independent effect of BRAF mutation on the recurrence was analyzed by Cox regression and Cox proportional hazard analyses. All statistical tests were two-sided. [Results]: Recurrence of SI-PTC larger than 1.0 cm and 4.0 cm or less was 9.5% (21/221) vs 3.4% (11/319) in BRAF mutation vs wild-type BRAF patients, with a hazard ratio (HR) of 3.03 (95% confidence interval [CI] = 1.46 to 6.30) and a patient age- and sex-adjusted hazard ratio of 3.10 (95% CI = 1.49 to 6.45, P = .002). Recurrence rates of SI-PTC larger than 2.0 cm and 4.0 cm or less were 16.5% (13/79) vs 3.6% (5/139) in mutation vs wild-type patients (HR = 5.44, 95% CI = 1.93 to 15.34; and adjusted HR = 5.58, 95% CI = 1.96 to 15.85, P = .001). Recurrence rates of SI-PTC larger than 3.0 cm and 4 cm or less were 30.0% (6/20) vs 1.9% (1/54) in mutation vs wild-type patients (HR = 18.40, 95% CI = 2.21 to 152.98; and adjusted HR = 14.73, 95% CI = 1.74 to 124.80, P = .01). Recurrences of mutation-positive SI-PTC were comparable with those of counterpart invasive solitary PTC, around 20% to 30%, in tumors larger than 2.0 cm to 3.0 cm. BRAF mutation was associated with a statistically significant decrease in recurrence-free patient survival on KM analysis, particularly in SI-PTC larger than 2.0 cm and 4.0 cm or less. Similar results were obtained in conventional SI-PTC. The negative predictive values of BRAF m

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1257724584
Document Type :
Electronic Resource